Syndax Pharmaceuticals (SNDX) News Today → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free SNDX Stock Alerts $19.72 +0.22 (+1.13%) (As of 06/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 11 at 1:34 AM | americanbankingnews.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Recommendation of "Moderate Buy" by AnalystsJune 10 at 5:13 PM | marketbeat.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Acquired by Avoro Capital Advisors LLCAvoro Capital Advisors LLC lifted its stake in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 65.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,222,222 shares of the compaJune 8 at 4:00 PM | marketbeat.comSectoral Asset Management Inc. Makes New Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)Sectoral Asset Management Inc. purchased a new position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 92,060 shares of theJune 8 at 2:36 AM | americanbankingnews.comSyndax Pharmaceuticals (NASDAQ:SNDX) Rating Reiterated by HC WainwrightJune 7, 2024 | marketbeat.comUBS Group AG Has $6.28 Million Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)UBS Group AG increased its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 151.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 290,801 shares of the company's stock after acquiring an addJune 6, 2024 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $41.00 price objective on shares of Syndax Pharmaceuticals in a research note on Thursday.June 6, 2024 | marketbeat.comRafferty Asset Management LLC Buys 119,257 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)Rafferty Asset Management LLC increased its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 42.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 403,381 shares of the company's stock aftJune 6, 2024 | prnewswire.comSyndax Announces Plans to Advance into Phase 1b Portion of Trial Evaluating Revumenib in Relapsed or Refractory Metastatic MSS CRCJune 5, 2024 | prnewswire.comSyndax Announces Participation at the Goldman Sachs 45th Annual Global Healthcare ConferenceJune 3, 2024 | prnewswire.comSyndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)June 1, 2024 | marketbeat.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Stock Holdings Boosted by Axiom Investors LLC DEAxiom Investors LLC DE increased its position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 696.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 86,175 shares of the company's stock afMay 30, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Boosts Holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)Charles Schwab Investment Management Inc. raised its holdings in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 13.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 577,022 shares of tMay 27, 2024 | marketbeat.comFranklin Resources Inc. Takes Position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)Franklin Resources Inc. purchased a new position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,352,905 shares of the company's stock, vMay 25, 2024 | marketbeat.comTrexquant Investment LP Invests $3.10 Million in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)Trexquant Investment LP acquired a new stake in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm acquired 143,514 shares of the company's stock, valued at approximately $3May 23, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Teva Pharmaceutical (TEVA), Cencora (COR)May 22, 2024 | marketbeat.comBNP Paribas Financial Markets Purchases 44,906 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)BNP Paribas Financial Markets grew its holdings in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 38.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 162,905 shares of the company's stock after buyingMay 21, 2024 | marketbeat.comSyndax Pharmaceuticals' (SNDX) "Overweight" Rating Reaffirmed at JPMorgan Chase & Co.JPMorgan Chase & Co. reiterated an "overweight" rating and issued a $34.00 target price on shares of Syndax Pharmaceuticals in a research note on Tuesday.May 19, 2024 | marketbeat.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Shares Purchased by Panagora Asset Management Inc.Panagora Asset Management Inc. boosted its position in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 90.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 174,144 shares ofMay 16, 2024 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Down 3.7%Syndax Pharmaceuticals (NASDAQ:SNDX) Shares Down 3.7%May 15, 2024 | prnewswire.comSyndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of DirectorsMay 13, 2024 | markets.businessinsider.comSyndax Pharmaceuticals (SNDX) Gets a Buy from Stifel NicolausMay 12, 2024 | finance.yahoo.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call TranscriptMay 9, 2024 | markets.businessinsider.comBuy Rating for Syndax Pharmaceuticals Amid Strong Financials and Promising Drug CandidateMay 9, 2024 | marketbeat.comCitigroup Lowers Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $30.00Citigroup lowered their target price on shares of Syndax Pharmaceuticals from $32.00 to $30.00 and set a "buy" rating on the stock in a research report on Thursday.May 9, 2024 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Announces Earnings ResultsSyndax Pharmaceuticals (NASDAQ:SNDX - Get Free Report) issued its quarterly earnings results on Wednesday. The company reported ($0.85) EPS for the quarter, topping analysts' consensus estimates of ($0.96) by $0.11. During the same period in the previous year, the firm posted ($0.59) earnings per share.May 9, 2024 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) PT Raised to $40.00Stifel Nicolaus boosted their price target on Syndax Pharmaceuticals from $39.00 to $40.00 and gave the stock a "buy" rating in a report on Thursday.May 9, 2024 | marketbeat.comSyndax Pharmaceuticals' (SNDX) Buy Rating Reiterated at HC WainwrightHC Wainwright reaffirmed a "buy" rating and set a $41.00 target price on shares of Syndax Pharmaceuticals in a research report on Thursday.May 9, 2024 | finance.yahoo.comSyndax Pharmaceuticals Inc (SNDX) Q1 2024 Earnings Call Transcript Highlights: Strategic ...May 9, 2024 | prnewswire.comSyndax Announces Participation at the Bank of America Securities 2024 Health Care ConferenceMay 8, 2024 | msn.comSNDX Stock Earnings: Syndax Pharmaceuticals Beats EPS for Q1 2024May 8, 2024 | finanznachrichten.deSyndax Pharmaceuticals, Inc.: Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateMay 8, 2024 | prnewswire.comSyndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business UpdateMay 3, 2024 | prnewswire.comSyndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)May 2, 2024 | marketbeat.comSyndax Pharmaceuticals (SNDX) Scheduled to Post Earnings on WednesdaySyndax Pharmaceuticals (NASDAQ:SNDX) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports.May 1, 2024 | prnewswire.comSyndax to Announce First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 8, 2024April 28, 2024 | marketbeat.comJennison Associates LLC Sells 2,296,893 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)Jennison Associates LLC reduced its position in shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX - Free Report) by 97.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 50,780 shares of the company's stock after selling 2,April 26, 2024 | markets.businessinsider.comBuy Rating Reaffirmed for Syndax Pharmaceuticals on Strong Drug Pipeline and Strategic PartnershipsApril 26, 2024 | marketbeat.comSyndax Pharmaceuticals' (SNDX) "Buy" Rating Reaffirmed at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $41.00 target price on shares of Syndax Pharmaceuticals in a research report on Friday.April 10, 2024 | finance.yahoo.comSyndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology ForumApril 10, 2024 | prnewswire.comSyndax Announces Participation at the Stifel 2024 Virtual Targeted Oncology ForumApril 8, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Syndax Pharmaceuticals (SNDX), Legend Biotech (LEGN)April 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for Syndax Pharmaceuticals Amidst Strong Clinical Results and Strategic Growth ProspectsApril 8, 2024 | prnewswire.comSyndax Presents Positive Pediatric Data from Pivotal AUGMENT-101 Trial of Revumenib in Relapsed/Refractory KMT2Ar Acute Leukemia at ASPHO Plenary SessionApril 6, 2024 | finanznachrichten.deSyndax Pharmaceuticals, Inc.: Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)April 3, 2024 | msn.comCrinetics Pharmaceuticals gains amid pitch at Sohn charity conference (update)March 29, 2024 | msn.com20 European Cities with Highest Weed ConsumptionMarch 29, 2024 | msn.comThis longevity company is letting you check the ‘credit score’ for your health. Here are my surprising results and biological ageMarch 28, 2024 | msn.comSyndax (SNDX) Gets FDA Priority Tag for Leukemia Drug NDAMarch 28, 2024 | finance.yahoo.comSyndax Announces Completion of Enrollment in AUGMENT-101 Pivotal Trial Cohort of Patients with Relapsed/Refractory mNPM1 Acute Myeloid LeukemiaMarch 28, 2024 | seekingalpha.comSyndax Pharmaceuticals: Upcoming Q3 PDUFAs Ignite Hope Get Syndax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Top 5 Tech Stocks to Buy for 2024 (Ad)The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", SNDX Media Mentions By Week SNDX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNDX News Sentiment▼0.780.75▲Average Medical News Sentiment SNDX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNDX Articles This Week▼93▲SNDX Articles Average Week Get Syndax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PTGX News AMPH News ENTA News BPMC News VKTX News IONS News OGN News MDGL News SMMT News BBIO News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNDX) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredMissed NVDA? Buy this AI stock NOWAfter Nvidia's record-breaking earnings surge, Wall Street is now selling the stock at the fastest pace in sev...Chaikin Analytics | Sponsored